|
Real-time
OTC Markets
10:57:58 2026-06-03 EDT
|
5-day change | 1st Jan Change | ||
| 0.1052 USD | -2.09% |
|
-22.00% | -87.61% |
| 08-14 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-13 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 2.65M 2.28M 2.15M 1.95M 3.66M 252M 3.67M 25.42M 9.83M 128M 9.94M 9.73M 407M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 24.5M 21.08M 19.85M 18.09M 33.84M 2.33B 33.98M 235M 90.94M 1.19B 92M 90M 3.76B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.62% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.09% | ||
| 1 week | -22.00% | ||
| Current month | -18.25% | ||
| 1 month | -18.25% | ||
| 3 months | +2.73% | ||
| 6 months | -49.86% | ||
| Current year | -87.61% |
| 1 week | 0.11 |  | 0.15 |
| 1 month | 0.11 | | 0.16 |
| Current year | 0.05 | | 1.2 |
| 1 year | 0.05 | | 2.49 |
| 3 years | 0.05 | | 8.48 |
| 5 years | 0.05 | | 15.7 |
| 10 years | 0.05 | | 88.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 2025-07-20 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 2025-05-15 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 2013-03-31 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 2023-03-20 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 2023-03-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/18/26 | Emerging Technology Partners LLC
| Other | Company | 1,097,341 | 7.0830% | |
| 3/18/26 | Panacea Venture
| Other | Company | 4,529,956 | 29.2393% | |
| 3/18/26 | Other | Chief Financial Officer | 75,000 | 0.4841% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.09% | -22.00% | -95.50% | -95.15% | 2.65M | |
| +0.56% | -2.71% | +49.50% | +89.43% | 1,002B | |
| -0.01% | -4.35% | +51.50% | +63.73% | 644B | |
| +0.51% | -3.04% | +19.21% | +69.29% | 443B | |
| -0.56% | -2.95% | +30.03% | +36.27% | 343B | |
| +0.65% | -14.45% | +11.51% | +27.21% | 262B | |
| +1.09% | -3.29% | -1.41% | +11.85% | 245B | |
| -2.18% | -13.58% | +37.81% | +46.65% | 212B | |
| -0.90% | -5.06% | -18.47% | -58.14% | 199B | |
| -1.09% | -4.76% | +24.96% | +86.94% | 181B | |
| Average | -0.40% | -4.50% | +10.92% | +27.81% | 352.97B | |
| Weighted average by Cap. | +0.04% | -4.24% | +32.04% | +56.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 24.56M 23.12M 21.07M 39.42M 2.72B 39.58M 274M 106M 1.38B 107M 105M 4.38B | 20.71M 17.82M 16.78M 15.29M 28.61M 1.97B 28.72M 199M 76.87M 1B 77.77M 76.08M 3.18B |
| Net income | -39.26M -33.78M -31.81M -28.98M -54.23M -3.74B -54.44M -377M -146M -1.9B -147M -144M -6.03B | -48.06M -41.35M -38.94M -35.48M -66.38M -4.57B -66.65M -461M -178M -2.33B -180M -177M -7.38B |
| Net Debt | 6.05M 5.21M 4.9M 4.47M 8.36M 576M 8.39M 58.1M 22.45M 293M 22.72M 22.22M 929M | 21.85M 18.81M 17.71M 16.13M 30.19M 2.08B 30.31M 210M 81.11M 1.06B 82.06M 80.28M 3.36B |
Employees
214
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | US$0.1288 | -4.59% | 6,342 |
| 26-09-08 | US$0.1350 | -11.76% | 12,155 |
| 26-09-04 | US$0.1530 | -.--% | 682 |
| 26-09-03 | US$0.1530 | +13.33% | 669 |
| 26-09-02 | US$0.1350 | +4.81% | 1,498 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CASIF Stock
Select your edition
All financial news and data tailored to specific country editions
